Gene Query: CPM

Dataset Description Geneva Score
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 135.05
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 73.04
Nutritional control of protein translation 67.32
Rorc disruption in human FG pancreatic cancer cells 63.78
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 59.84
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 56.69
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 56.69
circRNA-sequencing 56.09
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 55.51
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 55.51
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 51.2
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 51.2
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 50.53
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 50.37
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 50.36
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 43.72
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 42.44
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 37.68
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 37.68
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 37.51
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 35.37
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 35.37
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 34.11
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 31.55
RNA sequencing of BT142 and TS603 cell lines 31.51
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 31.51
BAF controls genome accessibility 31.37
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 31.25
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 30.57
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 30.23
Gene expression analysis of immortalized human liver progenitor-like cells in culture 30.0
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 29.95
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 29.92
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 29.8
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 29.5
Endometrial transcriptome and PGR cistrome in cycling fertile women 29.5
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 29.48
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 29.26
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 29.26
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 27.62
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 26.2
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 26.18
Primary human trophoblast from term placenta 25.85
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 25.73
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 25.21
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 25.15
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 24.83
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 24.47
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 24.22
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 24.08
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 24.06
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 23.7
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 23.34
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 22.84
Role of CD133 molecule in WNT response and renal repair 22.77
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 22.46
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 22.32
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 22.25
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 22.16
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 22.02
Region-specific Innate Antiviral Responses of the Human Epididymis 22.0
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 21.66
A549 cell transcriptome responses to infection with H7N9 influenza virus 21.52
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 21.12
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 21.06
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 21.03
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 20.98
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 20.56
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 20.03
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 19.84
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 19.84
Polarized B -cell functions 19.75
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 19.67
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 19.66
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 19.63
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 19.46
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 19.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 19.15
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 18.74
Transcriptome analysis of human lung epithelial cells 18.64
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 18.57
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 18.21
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 18.01
Transcriptional profiles of normal human mature B cells 17.96
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 17.88
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 17.74
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 17.74
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 17.72
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 17.7
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 17.69
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 17.47
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 17.47
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 17.43
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 17.43
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 17.43
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 17.13
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 17.07
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 16.94
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 16.59
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 16.56
RNA-seq analysis of AML cells in response to ASLAN003 16.15
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 15.78
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 15.65
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 15.25
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 15.18
Accurate annotation of human protein-coding small open reading frames 14.96
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 14.75
Transcriptomic profiling of human peripheral blood-derived mast cells 14.72
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 14.72
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 14.71
ARID1A regulates condensin II distribution and chromosomal partition 14.56
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 14.56
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 14.44
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 14.22
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 14.22
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 14.17
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 14.17
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 14.17
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 14.05
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 13.91
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 13.78
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 13.62
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 13.58
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 13.5
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 13.47
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 13.17
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 13.17
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.03
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.03
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 12.98
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 12.89
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 12.89
Oncogenic MYC induces a dependency on the spliceosome in human cancer 12.64
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 12.64
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 12.59
Characterization of parental and rociletinib-resistant derived H1975 cell lines 12.57
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 12.46
Transcriptome of human white and brown adipose tissue biopsies 12.38
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 12.36
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 12.34
Chromatin landscape of human visceral and subcutaneous adipocytes 12.33
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 12.23
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 12.15
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 12.11
Gene expression analysis of the impact of TDP-43 knockout in human cells. 11.87
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 11.79
Fibroblasts in cholesteatoma activate osteoclasts. 11.71
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 11.7
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 11.7
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 11.62
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.59
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 11.56
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 11.47
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 11.47
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 11.45
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 11.38
Regulation of Lipids is Central to Replicative Senescence 11.38
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 11.24
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 11.23
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 11.18
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 11.14
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 10.92
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 10.92
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 10.78
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 10.78
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 10.78
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 10.62
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 10.47
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 10.46
RNA-seq analyisis of PUM2 knockout cells 10.4
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 10.37
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 10.37
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 10.32
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 10.31
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 10.29
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 10.28
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 10.28
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 10.28
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 10.26
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 10.21
Aortic Valve Tissue: Stenosis vs. Sclerosis 10.16
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.14
STRIPAK directs PP2A activity to promote oncogenic transformation 9.95
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 9.81
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 9.73
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 9.6
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 9.54
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 9.53
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 9.45
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 9.43
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 9.29
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 9.29
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 9.27
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 9.25
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 9.19
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 9.16
Direct Isolation and Characterization of Human Nephron Progenitors. 9.15
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 9.13
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 9.07
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 9.07
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 9.03
Efficient derivation of microglia-like cells from human pluripotent stem cells 8.95
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 8.94
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 8.89
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 8.79
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 8.72
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.71
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 8.61
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 8.51
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 8.5
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.45
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.45
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 8.43
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 8.43
The pioneer factor CEBPA modulates vitamin D signaling 8.43
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 8.43
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 8.36
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 8.36
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.35
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 8.35
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 8.33
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 8.2
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 8.17
Trascriptome of thyroid cancer-induced macrophages 8.16
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 8.13
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 8.13
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 8.11
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 8.1
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 8.06
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 8.06
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 8.06
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 8.01
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.94
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 7.85
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 7.85
Silencing SPIB in attached and floating state of H1703 lung cancer cells 7.8
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 7.77
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.77
T47D RNA-seq and ChrRNA-seq data 7.77
Gene expression alterations of pancreatic intraepithlial neoplasia 7.73
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 7.69
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 7.63
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 7.58
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 7.56
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 7.55
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 7.55
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.54
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.54
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 7.54
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 7.53
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 7.53
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.52
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 7.43
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 7.41
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 7.4
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 7.36
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 7.36
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 7.36
Recovery and analysis of nascent RNA 7.36
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.35
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 7.26
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 7.24
Non-coding regions are the main source of tumor-specific antigens [human] 7.23
Non-coding regions are the main source of tumor-specific antigens 7.23
Expression by CD133+ cells isolated from the adult human exocrine pancreas 7.22
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 7.17
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 7.17
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.16
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 7.15
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 7.08
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 7.08
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.07
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 7.06
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 7.05
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 7.03
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.99
BACH2 in human plasma cell fate decision 6.97
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 6.89
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 6.86
RNA seq comparison between scrambled and shGRP78 cells 6.84
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 6.82
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.81
Targeting MTHFD2 in Acute Myeloid Leukemia 6.8
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 6.72
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 6.66
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 6.65
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 6.64
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 6.6
MARCKS and lnc-MARCKS act as inflammation regulators 6.58
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 6.58
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 6.55
Nonpregnant and term pregnant human myometrial tissues 6.55
Morphological and molecular characterization of human dermal lymphatic collectors 6.51
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 6.44
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 6.34
Gene expression patterns define the hepatocyte-like cells derived by different strategies 6.34
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.23
Global analyses of the effect of different cellular contexts on microRNA targeting 6.22
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 6.22
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 6.18
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 6.13
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 6.12
Effect of ILF3 on translation during homeostasis and the antiviral response 6.12
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 6.07
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 6.07
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 6.03
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 6.02
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.97
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 5.96
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 5.9
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 5.9
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 5.8
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 5.8
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 5.79
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 5.76
Gene expression changes in human melanoma cell lines compared to primary melanocytes 5.76
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 5.74
Effect of BMP inhibition or stimulation of primary human keratinocytes 5.74
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 5.69
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 5.67
Transcriptomic analysis of human tonsillar TFH subsets 5.66
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 5.58
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 5.58
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 5.57
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.5
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.5
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.47
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 5.42
Effects of rFVIIIFc on human macrophages 5.38
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.37
Transcriptomes of human monocytes after ex vivo exposure to uric acid 5.34
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 5.28
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 5.24
Identification of global regulators of T-helper cell lineage specification 5.23
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.23
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 5.22
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 5.17
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 5.17
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 5.16
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 5.11
Modeling Familial Cancer with iPSC Approaches 5.08
Genome-wide mapping of TEL-AML1 targets in acute leukemia 5.04
Gene expression profile of human placenta from T. Cruzi infected mothers 4.99
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 4.99
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.96
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 4.89
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 4.89
Gene profiling of human adult and pediatric liver cancer cells 4.88
siRNA-mediated knockdown 4.83
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 4.79
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.75
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.7
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 4.61
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.58
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.56
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 4.55
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 4.54
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 4.52
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 4.5
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 4.31
Age-Related Gene Expression Changes in Prostate Cancer Patients 4.08
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 4.08
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 4.03
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 4.0
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 4.0
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 3.98
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 3.86
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 3.8
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 3.79
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.79
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 3.71
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 3.71
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 3.69
Generation and functional characterization of MDSC-like cells 3.68
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 3.59
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 3.59
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.43
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 3.42
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 3.4
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.39
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 3.38
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 3.33
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.33
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.21
The transcriptome of Kawasaki Disease arteritis 3.13
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.09
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.05
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 3.01
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.0
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 2.98
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 2.98
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 2.93
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 2.93
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.91
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 2.91
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.91
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 2.89
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.88
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.83
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.79
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 2.77
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 2.71
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.66
Transcriptomes of oxLDL exposed trained monocytes 2.64
oxLDL exposed trained monocytes 2.64
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.63
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 2.55
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.52
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.36
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.35
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 2.3
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.23
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.23
Molecular analysis of renal cell carcinoma with unclassfied histology 2.22
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.22
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.21
Changes in human endometrial gland transcriptome over the window of implantation 2.05
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.01
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 2.01
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.0
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 1.96
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.94
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.94
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.92
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.92
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.85
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.85
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.85
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.85
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.84
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 1.83
RNA-seq of CD33 KO and control HSPCs 1.77
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.77
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.77
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.73
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 1.71
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 1.71
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 1.7
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 1.7
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 1.7
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 1.64
Multiple sclerosis and EAE 1.61
Human optic chiasm from healthy controls and multiple sclerosis patients 1.61
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.6
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 1.55
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.53
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 1.45
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.44
ML29755 RNA-seq data 1.42
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.41
Clinker: visualizing fusion genes detected in RNA-seq data 1.39
RNA sequencing of human pancreatic cancer cell lines 1.33
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.29
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.25
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.24
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 1.22
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 1.17
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 1.17
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.05
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.98
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 0.96
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.95
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.85
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.83
A single-cell transcriptome atlas of the human pancreas 0.83
Gene expression of thyroid cancer cell lines 0.77
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.68
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.67
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.64
NHLRC1 re-expression in cancer cells 0.64
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.62
hNSCs siRNA NOVA2 0.6
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.57
Reprogrammed myeloid cell transcriptomes in NSCLC 0.57
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.47
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 0.47
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.37
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 0.35
The gene expression profiles of gallbladder cancer 0.34
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.34
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.32
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.3
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 0.3
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 0.3
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.3
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 0.26
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.22
Gene expression profiling in metabolically heterogeneous human lung tumors 0.22
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.16
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.14
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.14
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.13
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 0.13
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 0.13
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.11
Loss of endometrial plasticity in recurrent pregnancy loss 0.05
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 0.05
RNA-Seq and expression data from human adipose tissue 0.05
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.05
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation